Mark Luedde
- Cancer Research top 2%
- MicroRNA in disease regulation 12
- Hepatology top 5%
-
- Cardiovascular Function and Risk Factors 7
- Cardiovascular Effects of Exercise 6
- Heart Failure Treatment and Management 6
- Cardiomyopathy and Myosin Studies 4
- Molecular Biology top 5%
- Circular RNAs in diseases 9
- Extracellular vesicles in disease 6
- Epidemiology top 5%
- Liver Disease Diagnosis and Treatment 8
- Co-authors
- Norbert FreyTom LueddeChristoph RoderburgChristian TrautweinMihael VucurFrank TackeHugo A. KatusDavid Vargas Cardenas
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Mark Luedde
75 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 121
- Cancer Research 717
- Hepatology 199
- Cardiology and Cardiovascular Medicine 501
- Molecular Biology 1.5k
- Epidemiology 613
Countries citing papers authored by Mark Luedde
This map shows the geographic impact of Mark Luedde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Luedde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Luedde more than expected).
Fields of papers citing papers by Mark Luedde
This network shows the impact of papers produced by Mark Luedde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Luedde. The network helps show where Mark Luedde may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark Luedde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 21 | |
| 6 | 2023 | 2 | |
| 7 | 2022 | 10 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 2 | |
| 10 | 2021 | 14 | |
| 11 | 2021 | 77 | |
| 12 | 2020 | 41 | |
| 13 | 2019 | 11 | |
| 14 | 2017 | 232 | |
| 15 | 2016 | 17 | |
| 16 | 2014 | 111 | |
| 17 | 2012 | 104 | |
| 18 | 2012 | 90 | |
| 19 | 2011 | 168 | |
| 20 | 2010 | 45 |
About Mark Luedde
Mark Luedde is a scholar working on Cancer Research, Hepatology and Cardiology and Cardiovascular Medicine, having authored 76 papers that have together received 2.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (12 papers), Circular RNAs in diseases (9 papers), Liver Disease Diagnosis and Treatment (8 papers), Cardiovascular Function and Risk Factors (7 papers), Cardiovascular Effects of Exercise (6 papers), Heart Failure Treatment and Management (6 papers), Extracellular vesicles in disease (6 papers) and Cardiomyopathy and Myosin Studies (4 papers). The work is most often cited by research in Cancer Research (717 citations), Hepatology (199 citations) and Cardiology and Cardiovascular Medicine (501 citations). Mark Luedde has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Norbert Frey, Tom Luedde, Christoph Roderburg, Christian Trautwein, Mihael Vucur, Frank Tacke, Hugo A. Katus, David Vargas Cardenas, Alexander Koch and Jérémie Gautheron. Their work appears in journals such as Journal of Clinical Medicine, Disease Markers, PLoS ONE, Scientific Reports and Clinical Research in Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.